TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2026
Voltar para busca
Dado oficial do USPTO
X-PATH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
X-PATH
ST13
US500000088333627Classe
1, 5, 10, 42, 44
Pedido
88333627
Registro
6880311
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
50
Atualização mais recente
05/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42, 44
Data de depósito
11/03/2019
Data de registro
18/10/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/10/2022
Última transação
05/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2022-07-00
Primeiro uso no comércio
2022-07-00
Código do desenho
4
Tipo de titular
03
Localização do titular
Monmouth Junction, NJ, US
Examinador
MAIHOS, JESSIE ANDREA
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
E. C. (pessoa física)
Representantes
Xiongying Tu Schwabe, Williamson & Wyatt, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposesin vitro and in vivo scientific usethe testing of bodily fluidsthe detecting and analyzing of cellsproteinssmall moleculesnucleotides; Biological and chemical test kits comprised of biologicalchemicaldiagnostic reagents for the detection and identification of nucleic acidsDNA and RNA in a samplefor laboratory and research use
Classe 5
Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cellsproteinssmall moleculesnucleotidesnucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancersblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical test kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances extracted from bodily fluidscellsproteinssmall moleculesnucleotidesnucleic acids for use in disease detectioncancerblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseases
Classe 10
Medical diagnostic apparatus for testing cellstissuebiomoleculesproteinssmall moleculesnucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic usemedical apparatus for diagnostic testing of health conditionsdiseasesabnormalitiesin the fields of cancerblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseasesendocrine diseasesother tissue-based diagnostic testingcytologycell based testing; Medical apparatusdevicesinstruments for wellness testinghealth condition testinghealthcare testingpoint-of-care diagnostic devicesat-home diagnostic devicesportable health monitoring devices that detect health conditions and diseases in the nature of cancersblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseases and genetic diseases; Medical apparatusdevicesinstruments for the detection and identification of nucleic acidsDNA and RNA in a samplein the nature of apparatus for DNA and RNA testing for medical purposes
Classe 42
Scientific laboratory servicesdetection and identification of cellsproteinssmall moleculesnucleotides in a sample for scientificresearchtechnological purposes; Medical laboratory servicesproviding medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of infectious and residual diseasethe analysisevaluationreporting of those test results to help healthcare professionals for research purposes; Development of new technology for others in the fields of biotechnologyDNARNAsmall moleculesproteinsnucleotide analysis services for scientific research purposes; Providing medical and scientific research information in the field of clinical trialsassays and assay developmentdiagnosticscancerRNADNAsmall moleculesproteinsnucleotides; Research and development in the medical and digital diagnostics and biotechnology fields; Custom design and development of chemical reagents and biochemical assays; Laboratory research in the field of oncologyhematologyinfectious diseases
Classe 44
Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare servicesthe diagnosis of diseasescancerblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseases; Diagnostic servicesmedical testing for diagnostic purposes; Wellness servicesproviding wellness information in the fields of health and wellness; Medical services for the detection and identification of cellsproteinssmall moleculesnucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/03/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/03/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
18/10/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
14/09/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
13/09/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/08/2022
IUAF
USE AMENDMENT FILED
04/08/2022
EISU
TEAS STATEMENT OF USE RECEIVED
04/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/02/2022
EX4G
SOU EXTENSION 4 GRANTED
03/02/2022
EXT4
SOU EXTENSION 4 FILED
03/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/02/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/08/2021
EX3G
SOU EXTENSION 3 GRANTED
09/08/2021
EXT3
SOU EXTENSION 3 FILED
04/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27/01/2021
EX2G
SOU EXTENSION 2 GRANTED
25/01/2021
EXT2
SOU EXTENSION 2 FILED
25/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
25/01/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/11/2020
EX1G
SOU EXTENSION 1 GRANTED
12/11/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/11/2020
NREV
NOTICE OF REVIVAL - E-MAILED
29/09/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
29/09/2020
PETG
PETITION TO REVIVE-GRANTED
29/09/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
29/09/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
08/09/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
07/09/2020
EXT1
SOU EXTENSION 1 FILED
04/08/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/02/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2019
PUBO
PUBLISHED FOR OPPOSITION
10/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/11/2019
ALIE
ASSIGNED TO LIE
07/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
04/11/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/11/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
04/11/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/05/2019
GNRT
NON-FINAL ACTION E-MAILED
08/05/2019
CNRT
NON-FINAL ACTION WRITTEN
08/05/2019
DOCK
ASSIGNED TO EXAMINER
06/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/03/2019
NWAP
NEW APPLICATION ENTERED
14/03/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace X-PATH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.